Clinical Trial Update: The Effect of Preoperative Intravenous Ferric Derisomaltose and EPO and Tranexamic Acid in Patients With Preoperative Anemia or Iron Deficiency in Bone Tumor [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating preoperative intravenous ferric derisomaltose, erythropoietin (EPO), and tranexamic acid for patients with preoperati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Bone Cancer
• Iron Deficiency Anemia

Drugs mentioned

• EPOETIN ALFA (EPOETIN ALFA)
• Ferric derisomaltose (ferric derisomaltose)
• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Tang Xiaodong | Conditions: Anemia | Phase 4 | Status: NOT_YET_RECRUITING